Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022).,Journal of Clinical and Translational Hepatology

当前位置： X-MOL 学术 › J. Clin. Transl. Hepatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022).
Journal of Clinical and Translational Hepatology ( IF 3.6 ) Pub Date : 2023-08-15 , DOI: 10.14218/jcth.2023.00320
Hong You ₁ , Fusheng Wang ₂ , Taisheng Li ₃ , Xiaoyuan Xu ₄ , Yameng Sun ₁ , Yuemin Nan ₅ , Guiqiang Wang ₄ , Jinlin Hou ₆ , Zhongping Duan ₇ , Lai Wei ₈ , Jidong Jia ₁ , Hui Zhuang ₉ ,

Affiliation

To facilitate the achieving of the goal of "eliminating viral hepatitis as a major public health threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology together with the Chinese Society of Infectious Diseases (both are branches of the Chinese Medical Association) organized a panel of experts and updated the guidelines for prevention and treatment of chronic hepatitis B in China (version 2022). With the support of available evidence, this revision of the guidelines focuses on active prevention, large scale testing, and expansion of therapeutic indication of chronic hepatitis B with the aim of reducing the hepatitis B related disease burden.

更新日期：2023-08-15

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文

全部期刊列表>>